Growth potential Small scale clinical consulting firm with Belgium focus and aims to expand expertise beyond recruitment, indicating opportunities to upsell end-to-end CRO services, regulatory support, medical affairs, and project management for mid-market biotech and pharma clients in Europe.

Strategic partnerships Positioning as flexible experts for defined project lifecycles suggests alignment with sponsors needing interim CRAs, PMs, regulatory and medical affairs consultants on a temporary basis, opening entry points with emerging biotechs and mid-size pharma seeking augmented teams.

Market positioning Compared to larger CROs, FirstWave emphasizes specialized science-driven support and first-wave expertise; sales angles include personalized service, rapid onboarding, and scope for tailored consulting packages to accelerate product-to-market timelines.

Regional footprint Based in Brussels with Antwerp presence and a Belgian market focus, there are opportunities to expand in the Benelux region and neighboring EU markets through collaborations, co-marketing, or joint bids for regulatory submissions and clinical trials.

Traction signals Recent recognition via media coverage and awards related to healthcare narratives can be leveraged to demonstrate credibility; combine with client case studies for risk reduction, and target pharmaceutical companies investing in clinical development in EU markets.